Figure 1 Retrosynthetic strategy for lycopodine. |
Scheme 1 Synthesis of the Keto Sulfone Subunit |
Scheme 2 Diastereoselective Intramolecular Michael Addition and ORTEP Representation of Keto Sulfone 3 |
Scheme 3 Total Synthesis of Lycopodine |
![]() | ![]() |
Formats:
|
||||||||||||
Enantioselective Total Synthesis of Lycopodine Department of Chemistry, Oregon State University, 153 Gilbert Hall, Corvallis, Oregon 97331 †Director of the X-ray Crystallographic Facility of the Departments of Chemistry at Oregon State University and the University of Oregon. E-mail: rich.carter/at/oregonstate.edu The publisher's final edited version of this article is available at J Am Chem Soc.The lycopodium family of alkaloids has garnered considerable attention over the years because of their wide-ranging biological activity and structural complexity.1 The parent member of this family, lycopodine (1), was isolated 125 years ago by Bödeker (Figure 1
The synthesis commenced with the known ester 6,6 which is readily accessible in two steps from commercially available acyl sultam 5 (Scheme 1
Our attention then turned to the key intramolecular Michael addition of keto sulfone 4 (Scheme 2
We next turned to the key Mannich cyclization step (Scheme 3
In conclusion, we have completed the first enantioselective total synthesis of lycopodine. This approach should open the door to accessing other lycopodium alkaloids. Further synthetic studies will be reported in due course. Experimental Procedures Click here to view.(327K, pdf) Spectral Data Click here to view.(1.2M, pdf) Crystallographic Data Click here to view.(7.2M, pdf) CIF file 006 Click here to view.(19K, cif) CIF file 007 Click here to view.(19K, cif) Acknowledgment Financial support was provided by the National Institutes of Health (GM63723). The authors would like to thank Professor Clayton Heathcock (UC-Berkeley) for providing an authentic sample of 1 and Professor Max Deinzer and Dr. Jeff Morré (OSU) for mass spectral data. Finally, the authors are grateful to Professor James D. White (OSU), Professor Paul R. Blakemore (OSU), and Dr. Roger Hanselmann (Rib-X Pharmaceuticals) for helpful discussions. Footnotes Supporting Information Available: Complete experimental procedures, including 1H and 13C spectra, for all of the new compounds, and crystallographic data and CIF files for 3 and 19. This material is available free of charge via the Internet at http://pubs.acs.org. References 1. a. Kobayashi J, Morita H. Alkaloids. 2005;61:1–57. [PubMed] b. Ma X, Gang DR. Nat. Prod. Rep. 2004;21:752–772. [PubMed] 2. a. Bödeker K. Justus Liebigs Ann. Chem. 1881;208:363. b. Achmatowicsz O, Uzieblo W. Rocz. Chem. 1938;18:88–95. c. Ayer WA, Iverach GG. Tetrahedron Lett. 1962:87–92. d. Rogers D, Quick A, Hague M. Acta Crystallogr. 1974;B30:552–553. e. Hague M, Rogers D. J. Chem. Soc., Perkin Trans. 1975;2:93–98. 3. Nikonorow M. Acta Pol. Pharm. 1939;3:23–56. 4. Ortega MG, Agnese AM, Cabrera JL. Phytomedicine. 2004;11:539–543. [PubMed] 5. a. Stork G, Kretchmer RA, Schlessinger RH. J. Am. Chem. Soc. 1968;90:1647–1648. [PubMed] b. Ayer WA, Bowman WR, Joseph TC, Smith P. J. Am. Chem. Soc. 1968;90:1648–1650. [PubMed] c. Kim S, Bando Y, Horii Z. Tetrahedron Lett. 1978:2293–2294. [PubMed] d. Heathcock CH, Kleinman EF, Binkley ES. J. Am. Chem. Soc. 1982;104:1054–1068. [PubMed] e. Schumann D, Mueller HJ, Naumann A. Liebigs Ann. Chem. 1982:1700–1705. [PubMed] f. Kraus GA, Hon YS. Heterocycles. 1987;25:377–386. [PubMed] g. Grieco PA, Dai Y. J. Am. Chem. Soc. 1998;120:5128–5129. [PubMed] i. Mori M, Hori K, Akashi M, Hori M, Sato Y, Nishida M. Angew. Chem., Int. Ed. 1998;37:637–638. [PubMed]For formal syntheses of lycopodine, see: Padwa A, Brodney MA, Jr., Sheehan SM J. Org. Chem. 1997;62:78–87. [PubMed]. 6. Boulet SL, Paquette LA. Synthesis. 2002:895–900. 7. Zhou X-T, Carter RG. Angew. Chem., Int. Ed. 2006;45:1787–1790. 8. Garber SB, Kingsbury JS, Gray BL, Hoveyda AH. J. Am. Chem. Soc. 2000;122:8168–8179. 9. We purchased 10 (70% pure) from Aldrich Flavors and Fragrances (Aldrich cat. no. W341703, 25 g, $92). The impurity (mesityl oxide) did not affect the performance of the cross metathesis. Alternate sources of 10 were significantly higher in cost and less pure. 10. a. Padwa A, Bullock WH, Dyszlewski AD. Tetrahedron Lett. 1987;28:3193–3196. b. Ogura K, Iihama T, Kiuchi S, Kajiki T, Koshikawa O, Takahashi K, Iida H. J. Org. Chem. 1986;51:700–705. c. Lin P, Whitman GH. J. Chem. Soc., Chem. Commun. 1983:1102–1103. d. Baechler RD, Bentley P, Deuring L, Fisk S. Tetrahedron Lett. 1982;23:2269–2272.For Pd-catalyzed methods, see: Jagusch T, Gais H-J, Bondarev O J. Org. Chem. 2004;69:2731–2736. [PubMed], and references cited within. 11. The heterolytic cleavage would appear unlikely given the tethered nucleophile in the form of the silyl enol ether. 12. Hatanaka N, Ozaki O, Matsumoto M. Tetrahedron Lett. 1986;27:3169–3172.Also see: Knight DJ, Whitman GH, Williams JG J. Chem. Soc., Perkin Trans. 1987;1:2149–2152.. 13. A fourth option, involving formation of an intermediate 1,1-dioxothietane followed by ring opening, also exists. 14. Mahoney WS, Stryker JM. J. Am. Chem. Soc. 1989;111:8818–8823. 15. Nakashima TT, Singer PP, Browne LM, Ayer WA. Can. J. Chem. 1975;53:1936–1942. 16. Douglas B, Lewis DG, Marion L. Can. J. Chem. 1953;31:272–276. |
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||
Alkaloids Chem Biol. 2005; 61():1-57.
[Alkaloids Chem Biol. 2005]Phytomedicine. 2004 Sep; 11(6):539-43.
[Phytomedicine. 2004]J Am Chem Soc. 1968 Mar 13; 90(6):1647-8.
[J Am Chem Soc. 1968]J Am Chem Soc. 1968 Mar 13; 90(6):1647-8.
[J Am Chem Soc. 1968]